The prevalence of nystagmus: The leicestershire nystagmus survey

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 11, 2009, Pages 5201-5206

  Sarvananthan, Nagini ^a   Surendran, Mylvaganam ^a   Roberts, Eryl O ^a   Jain, Sunila ^b   Thomas, Shery ^a   Shah, Nitant ^a   Proudlock, Frank A ^a   Thompson, John R ^a   Mclean, Rebecca J ^a   Degg, Christopher ^a   Woodruff, Geoffrey ^a   Gottlob, Irene ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b ROYAL PRESTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN FRMD7; UNCLASSIFIED DRUG;

ADULT; ANIRIDIA; ARTICLE; CATARACT; CLINICAL FEATURE; COLOR BLINDNESS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETICS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROPHTHALMIA; NIGHT BLINDNESS; NYSTAGMUS; OPTIC NERVE HYPOPLASIA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RETINA DISEASE; STATISTICAL ANALYSIS; UNITED KINGDOM; VISION;

ADOLESCENT; ADULT; ETHNIC GROUPS; FEMALE; GREAT BRITAIN; HEALTH SURVEYS; HUMANS; MALE; NYSTAGMUS, PATHOLOGIC; PREVALENCE; QUESTIONNAIRES; SEX DISTRIBUTION;

EID: 70049083876     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3486     Document Type: Article

References (38)

1. Gottlob I. Nystagmus. Curr Opin Ophthalmol. 2000;11(5):330-335.
2. Jacobs JB, Dell'Osso LF. Congenital nystagmus: hypotheses for its genesis and complex waveforms within a behavioral ocular motor system model. J Vis. 2004;4(7):604-625.
3. Averbuch-Heller L, Tusa RJ, Fuhry L, et al. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol. 1997;41(6):818-825.
4. Bandini F, Castello E, Mazzella L, Mancardi GL, Solaro C. Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis? J Neurol Neurosurg Psychiatry. 2001;71(1):107-110.
5. Jain S, Proudlock F, Constantinescu CS, Gottlob I. Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis. Am J Ophthalmol. 2002;134(5):780-782.
6. Leigh RJ. A pilot study of gabapentin as treatment for acquired nystagmus. Neuro-Ophthalmology. 1996;16(2):107-113.
7. McLean R, Proudlock F, Thomas S, Degg C, Gottlob I. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/ gabapentin. Ann Neurol. 2007;61(2):130-138.
8. Sarvananthan N, Proudlock FA, Choudhuri I, Dua H, Gottlob I. Pharmacologic treatment of congenital nystagmus. Arch Ophthalmol. 2006;124(6):916-918.
9. Schon F, Hart PE, Hodgson TL, et al. Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology. 1999;53(9):2209-2210.
10. Shery T, Proudlock FA, Sarvananthan N, McLean RJ, Gottlob I. The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study. Br J Ophthalmol. 2006;90(7): 839-843.
11. Starck M, Albrecht H, Pollmann W, Straube A, Dieterich M. Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol. 1997;244(1):9-16.
12. Strupp M, Schuler O, Krafczyk S, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology. 2003;61(2):165-170.
13. Del Monte M, Hertle R. Extraocular muscle surgery for nystagmus. J Pediatr Ophthalmol Strabismus. 2006;43(4):200-204.
14. Hertle RW, Dell'Osso LF, FitzGibbon EJ, Yang D, Mellow SD. Horizontal rectus muscle tenotomy in children with infantile nystagmus syndrome: a pilot study. J AAPOS. 2004;8(6):539-548.
15. Tarpey P, Thomas S, Sarvananthan N, et al. Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus. Nat Genet. 2006;38(11):1242-1244.
16. Pilling RF, Thompson JR, Gottlob I. Social and visual function in nystagmus. Br J Ophthalmol. 2005;89(10):1278-1281.
17. Norn MS. Congenital idiopathic nystagmus: incidence and occupational prognosis. Acta Ophthalmol. 1964;42:889-896.
18. Hemmes G. Hereditary nystagmus. Am J Ophthalmol. 1927;10: 149-150.
19. Forssman B, Ringner B. Prevalence and inheritance of congenital nystagmus in a Swedish population. Ann Hum Genet. 1971;35(2): 139-147.
20. Stewart-Brown SL, Haslum MN. Partial sight and blindness in children of the 1970 birth cohort at 10 years of age. J Epidemiol Community Health. 1988;42(1):17-23.
21. Thompson JR, Woodruff G, Hiscox FA, Strong N, Minshull C. The incidence and prevalence of amblyopia detected in childhood. Public Health. 1991;105(6):455-462.
22. Census 2001, County Report. Leicestershire, UK: HMSO Office of Population Census and Survey; 2001.
23. Identification and notification of sight loss. http://www.dh.gov.uk/en/Healthcare/Primarycare/Optical/DH_4074843. Accessed June 28, 2009.
24. Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev. 1995;17(2):243-264.
25. Aitkin M, Anderson D, Francis B, Hinde J. Statistical Modelling in GLIM. Oxford: Clarendon Press; 1992.
26. Blohme J, Tornqvist K. Visual impairment in Swedish children, III: diagnoses. Acta Ophthalmol Scand. 1997;75(6):681-687.
27. DeCarlo DK, Nowakowski R. Causes of visual impairment among students at the Alabama School for the Blind. J Am Optom Assoc. 1999;70(10):647-652.
28. Pardhan S, Mahomed I. The clinical characteristics of Asian and Caucasian patients on Bradford's Low Vision Register. Eye. 2002; 16(5):572-576.
29. Schwarz K, Yeung S, Symons N, Bradbury J. Survey of school children with visual impairment in Bradford. Eye. 2002;16(5):530-534.
30. Robertson NP, Deans J, Fraser M, Compston DAS. Multiple sclerosis in the North Cambridgeshire districts of East Anglia. J Neurol Neurosurg Psychiatry. 1995;59:71-76.
31. Tsuda H, Ishikawa H, Matsunaga H, Mizutani T. A neuro-ophthalmological analysis in 80 cases of multiple sclerosis (in Japanese). Rinsho Shinkeigaku. 2004;44:513-521.
32. Rahi JS, Dezateux C. Capture-recapture analysis of ascertainment by active surveillance in the British Congenital Cataract Study. Invest Ophthalmol Vis Sci. 1999;40(1):236-239.
33. Yip PSF, Bruno G, Tajima N, et al. Capture-recapture and multiplerecord systems estimation, II: applications in human diseases. Am J Epidemiol. 1995;142(10):1059-1068.
34. Campbell H, Holmes E, MacDonald S, Morrison D, Jones I. A capture-recapture model to estimate prevalence of children born in Scotland with developmental eye defects. J Cancer Epidemiol Prev. 2002;7(1):21-28.
35. Rahi JS, Dezateux C. Measuring and interpreting the incidence of congenital ocular anomalies: lessons from a national study of congenital cataract in the UK. Invest Ophthalmol Vis Sci. 2001; 42(7):1444-1448.
36. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992; 99(6):933-943.
37. Chinnery PF, Johnson MA, Wardell TM, et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol. 2000; 48(2):188-193.
38. Mathew MR, Fern AI, Hill R. Retinopathy of prematurity: are we screening too many babies? Eye. 2002;16(5):538-542.